The country of origin is (b)(6).Product labeling states: "the coaguchek system uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas deviations can occur when compared to methods using other thromboplastins.However, those deviations between thromboplastins of different origin (e.G., rabbit based) are not specific to coaguchek products.Similar differences can be observed when a human recombinant thromboplastin based laboratory method is compared to other laboratory methods." the complained test strips have been calibrated against the who standard and are in scope of the roche initiated recall.For these test strips there is a potential for a product problem when the inr is > 4.5.Values > 4.5 inr showed an increasing positive bias.The information in the case is consistent with the details of the recall and the issue has been fully investigated.The related retention test strips were tested in comparison to masterlot #286321-80 on internal reference meters.For this purpose, two human blood samples from marcumar donors and two internal reference meters were used.No error messages occurred.The corresponding retention material complies with the specification, based on requirements of the regularly retention testing process of the qc department.
|